Ireland· IE-PA-EU/1/20/1501/001-002
Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen
A somapacitan product containing somapacitan, registered in Ireland by Novo Nordisk A/S. The same ATC class is registered in 13 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Somapacitan is registered in 13 of 19 countries.
Countries holding a registration under ATC H01AC07 (somapacitan), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Somapacitan · ATC H01AC07
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Somapacitan
- Manufacturer
- Novo Nordisk A/S
- Country
- Ireland (IE)
- ATC code
- H01AC07
- ATC class
- Somapacitan
- Defined daily dose
- 0.6 mg, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/20/1501/001-002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
303 interactions on record for somapacitan.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Somapacitan · interactions on record
303 records
- 2 severe
- 296 moderate
- 5 minor
Most severe, free to view
- OmeprazoleA02BC01moderate
- PantoprazoleA02BC02moderate
- LansoprazoleA02BC03moderate
- RabeprazoleA02BC04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Somapacitan in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceSOGROYA 10 mg/1,5 ml, solution injectable en stylo prérempliNOVO NORDISK (DANEMARK)
- NetherlandsSogroya 10 mg/1,5 ml, oplossing voor injectie in een voorgevulde penNovo Nordisk A.S.
- CzechiaSOGROYANovo Nordisk A/S, Bagsvaerd
- CanadaSOGROYANOVO NORDISK CANADA INC
- SwitzerlandSogroya 10 mg/ 1.5 ml, Injektionslösung im FertigpenNovo Nordisk Pharma AG
- SpainSOGROYA 10 MG/1,5 ML SOLUCION INYECTABLE EN PLUMA PRECARGADANovo Nordisk A/S
- FinlandSogroyaNovo Nordisk A/S
- BelgiumSogroya 10 mg/1.5 mlNovo Nordisk
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Sogroya
- Norway · Sogroya
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/937fefce-9e8c-4492-be35-63ebffd9c0f4 GET /v1/drugs/937fefce-9e8c-4492-be35-63ebffd9c0f4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled pen",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"H01AC",
"H01AC07"
],
"strength": null,
"pa_number": "EU/1/20/1501/001-002",
"substances": [
"Somapacitan"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "31/03/2021",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about somapacitan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.